Dogwood Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -1,049 | -1,291 | -1,103 | -1,235 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -811 | -937 | -1,469 | -960 |
Cash | 3,020 | 2,379 | 3,316 | 4,786 |
Basic Shares | 27,757 | 19,257 | 19,257 | 19,257 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -5,296 | -12,247 | -15,960 | -10,346 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cash | 3,316 | 7,030 | 14,008 | 29,795 |
Basic Shares | 19,257 | 18,330 | 8,330 | 8,305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.14 |
2024-03-31 | -$1.67 |
2023-12-31 | -$1.43 |
2023-09-30 | -$1.61 |
